Advertisement
Advertisement
U.S. markets open in 5 hours 3 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Yield10 Bioscience, Inc. (YTEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.8200-0.1700 (-4.26%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close3.9900
Open4.0000
Bid0.0000 x 1000
Ask0.0000 x 1300
Day's Range3.7100 - 4.0600
52 Week Range3.7100 - 23.4900
Volume91,593
Avg. Volume161,473
Market Cap18.649M
Beta (5Y Monthly)1.26
PE Ratio (TTM)N/A
EPS (TTM)-2.4600
Earnings DateMar 14, 2022 - Mar 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for YTEN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Yield10 Bioscience, Inc.
    Mid Cap U.S. Pick List January 2022This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
    Rating
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more
  • GlobeNewswire

    Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference

    WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright Bioconnect Investment Conference, which is being held virtually from January 10 – 13, 2022. Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. Event: H.C. Wainwright

  • GlobeNewswire

    Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

    WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021. President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the co

  • GlobeNewswire

    Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference

    WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the Canola Week 2021 Conference taking place in virtual format November 30 through December 2, 2021. Dr. Snell will make a pre-recorded virtual presentation on December 2, 2021 as part of Canola Innovation Day during the session “Cutting Edge Molecular Technologies—Genome editing and quanti

Advertisement
Advertisement